Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOT vs SOX as neoadjuvant chemotherapy for locally advanced gastric cancer
NCT04384601Phase 3Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Sep 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur-gimeracil-oteracil in gastric cancer (GC), sponsored by Ruijin Hospital. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
tegafur-gimeracil-oteracil
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04384601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04384601.